Contineum Therapeutics, Inc.
CTNMBiotechnology
$9.33+1.97%As of Oct 29vs prior close
- Market cap
- $351M
- P/E (TTM)
- –
- From 52W high
- −46.90%
- EPS (LTM)
- -$1.72
- Revenue (YE24)
- $0
- Dividend yield
- 0.00%
Nomior Score
47
Steady ProfileBottom 42% of the scored universe
Growth—
Quality53
Value42
Momentum60
Resilience39
Growth
$0revenue, YE24
YE23 $50MYE24 $0
Connections
Revenue to profitYE23
45% of revenue became net profit.
Who owns it
2funds, 1 tracked portfolio